http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#Head
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#assertion
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#provenance
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#pubinfo
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#assertion
http://purl.obolibrary.org/obo/DOID_2965
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_2965
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00328
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association
http://www.w3.org/2000/01/rdf-schema#label
carefully consider the potential benefits and risks of indomethacin extended release capsules usp 75 mg and other treatment options before deciding to use indomethacin extended release capsules usp 75 mg use the lowest effective dose for the shortest duration consistent with individual patient treatment goals see warnings indomethacin extended release capsules usp 75 mg has been found effective in active stages of the following 1 moderate to severe rheumatoid arthritis including acute flares of chronic disease 2 moderate to severe ankylosing spondylitis 3 moderate to severe osteoarthritis 4 acute painful shoulder bursitis and or tendinitis indomethacin extended release capsules usp 75 mg are not recommended for the treatment of acute gouty arthritis indomethacin may enable the reduction of steroid dosage in patients receiving steroids for the more severe forms of rheumatoid arthritis in such instances the steroid dosage should be reduced slowly and the patients followed very closely for any possible adverse effects the use of indomethacin in conjunction with aspirin or other salicylates is not recommended controlled clinical studies have shown that the combined use of indomethacin and aspirin does not produce any greater therapeutic effect than the use of indomethacin alone furthermore in one of these clinical studies the incidence of gastrointestinal side effects was significantly increased with combined therapy see precautions drug interactions
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00328
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#provenance
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#pubinfo
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#sig
http://purl.org/nanopub/x/hasSignature
Uq+QYY0+7BbOkOyqXC3BAPdPNy9JqPad6CqKXJaCTyLSzda8k2PpZx6x3ivooSFS9TlISED75BH48R3IfCfO23FvHtVtbLE8kFe+DMUjfHyrJlB3gZ9M+gTwvCxtwBmQdpCq8/XEJNp56/iJT15gB7Qlx5wCqaVqjE+QNjFoBnM=
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g
http://purl.org/dc/terms/created
2021-06-13T12:42:24.333+02:00
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAA8U2tNMkhf_VdbTXnlS4kr9xusyLmWsgZn4UyNz-S9g
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs